IGF-II
Showing 1 - 25 of >10,000
Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal Trial in Los Angeles, Bethesda (Dasatinib, Ganitumab)
Terminated
- Rhabdomyosarcoma
- +2 more
-
Los Angeles, California
- +1 more
Mar 17, 2022
HER2/Neu Negative, No Evidence of Disease, One or More Positive Axillary Nodes Trial in Seattle, Madison (Laboratory Biomarker
Active, not recruiting
- HER2/Neu Negative
- +10 more
- Laboratory Biomarker Analysis
- +2 more
-
Seattle, Washington
- +1 more
Jan 11, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +19 more
- pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 1, 2022
Breast Cancer Female, Breast Cancer, Male, Breast Cancer Stage I Trial in United States (DC1 Vaccine, WOKVAC Vaccine)
Recruiting
- Breast Cancer Female
- +7 more
- DC1 Vaccine
- WOKVAC Vaccine
-
Tampa, Florida
- +6 more
Apr 4, 2022
Breast Cancer Female Trial in Bani Suwayf (MetFORMIN 500 Mg Oral Tablet, Chemotherapy)
Completed
- Breast Cancer Female
- MetFORMIN 500 Mg Oral Tablet
- Chemotherapy
-
Banī Suwayf, EgyptMarian S. Boshra
May 2, 2023
Role of LncRNA H19 in The Regulation of IGF-1R Expression
Completed
- Hepatocellular Carcinoma
- +2 more
- Blood sample collection
-
Mansoura, Dakahliya, Egypt
- +1 more
Apr 5, 2022
Thymoma and Thymic Carcinoma Trial in Rozzano (Everolimus)
Completed
- Thymoma and Thymic Carcinoma
-
Rozzano, MI, ItalyIstituto Clinico Humanitas
Sep 8, 2022
Asthma; Eosinophilic Trial (Mepolizumab 100 MG)
Recruiting
- Asthma
- Eosinophilic Asthma
- Mepolizumab 100 MG
-
Ferrol, A Coruña, Spain
- +4 more
Sep 5, 2022
Insulin Growth Factor I Deficiency, IGF1 Deficiency, Executive Function Disorder Trial in Seville (HIIT, HIIT+PA, CON)
Recruiting
- Insulin Growth Factor I Deficiency
- +2 more
- HIIT
- +2 more
-
Seville, SpainEducation Faculty
Nov 30, 2022
Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, Iris Melanoma Trial in
Completed
- Ciliary Body and Choroid Melanoma, Medium/Large Size
- +5 more
- Cixutumumab
- Laboratory biomarker analysis
-
Philadelphia, Pennsylvania
- +1 more
Feb 5, 2020
Lung Cancer Trial in Hamilton, Ottawa, Toronto (anti-IGF-1R recombinant mAb MK-0646, cisplatin, etoposide)
Completed
- Lung Cancer
- anti-IGF-1R recombinant monoclonal antibody MK-0646
- +2 more
-
Hamilton, Ontario, Canada
- +2 more
Apr 6, 2020
Anorexia, Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Houston (Anamorelin Hydrochloride, Placebo,
Active, not recruiting
- Anorexia
- +8 more
- Anamorelin Hydrochloride
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Metastatic Ewing Sarcoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Bone Marrow Trial in Canada,
Active, not recruiting
- Metastatic Ewing Sarcoma
- +5 more
- Cyclophosphamide
- +11 more
-
Birmingham, Alabama
- +316 more
Jan 28, 2023
Prognostic Value of Protein IMP3 Expression in Cervical Cancer
Active, not recruiting
- Cervical Carcinoma
- immunohistochemical analysis with murine monoclonal antihuman antibodies IMP3
- (no location specified)
Jan 5, 2022
Children Born Small for Gestational Age Treated With Somatropin
Completed
- Growth Disorder
- Small for Gestational Age
-
Paris La Défense, FranceNovo Nordisk Investigational Site
Oct 19, 2022
Small for Gestational Age Infant, Growth Hormone Treatment, Cognitive Developmental Disorder Trial (PEG-rhGH)
Not yet recruiting
- Small for Gestational Age Infant
- +2 more
- (no location specified)
Dec 16, 2021
Metastatic Esophageal Adenocarcinoma, Metastatic Esophageal Squamous Cell Carcinoma, Metastatic Gastroesophageal Junction
Active, not recruiting
- Metastatic Esophageal Adenocarcinoma
- +7 more
- Cixutumumab
- +3 more
-
Scottsdale, Arizona
- +232 more
Nov 16, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Ductal Carcinoma In Situ Trial in
Not yet recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +3 more
- Biospecimen Collection
- +4 more
-
Houston, Texas
- +2 more
Aug 17, 2022
Breast Cancer, Hyperinsulinism, HER2-negative Breast Cancer Trial in New Haven (Dapagliflozin 10mg)
Not yet recruiting
- Breast Cancer
- +2 more
- Dapagliflozin 10mg
-
New Haven, ConnecticutYale Cancer Center Smilow Cancer Hospital
Aug 3, 2023
Mucopolysaccharidosis Type IIIB, MPS III B Trial in Worldwide (AX 250)
Active, not recruiting
- Mucopolysaccharidosis Type IIIB
- MPS III B
- AX 250
-
Oakland, California
- +7 more
Jan 16, 2023
Breast Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Philadelphia (Metformin
Active, not recruiting
- Breast Carcinoma
- +4 more
- Metformin Hydrochloride
- Doxycycline
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 28, 2022
Rehabilitation, Colorectal Cancer Survivor, Quality of Life Trial (multidimensional rehabilitation)
Not yet recruiting
- Rehabilitation
- +3 more
- multidimensional rehabilitation
- (no location specified)
Jul 21, 2023
Mammographically Dense Breast Trial in United States (Afimoxifene, Laboratory Biomarker Analysis, Placebo)
Active, not recruiting
- Mammographically Dense Breast
- Afimoxifene
- +3 more
-
Tampa, Florida
- +4 more
Dec 27, 2022
Localized Prostate Carcinoma, Locally Advanced Cervical Carcinoma, Locally Advanced Rectal Carcinoma Trial in Duarte (procedure,
Recruiting
- Localized Prostate Carcinoma
- +17 more
- Biospecimen Collection
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 1, 2023